A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples